跳转至内容
Merck
CN

MAB2052

抗-双唾液酸神经节苷脂GD2抗体,克隆14G2a

clone 14.2Ga, Chemicon®, from mouse

别名:

GD2检测抗体, 克隆14G2a抗GD2抗体, 抗GD2抗体

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗-双唾液酸神经节苷脂GD2抗体,克隆14G2a, clone 14.2Ga, Chemicon®, from mouse

biological source

mouse

antibody form

affinity purified immunoglobulin

antibody product type

primary antibodies

clone

14.2Ga, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

flow cytometry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable

isotype

IgG2a

shipped in

wet ice

target post-translational modification

unmodified

Quality Level

Application

免疫组织化学(冷冻组织切片)(Cheresh et al.,1986)

培养细胞的免疫荧光

流式细胞术:每10E6个细胞1-2 μg

对GD2阳性细胞的细胞毒性(Mujoo et al., 1987, 1989)

最佳工作稀释度必须由最终用户确定。
抗双唾液酸神经节苷脂抗体,clone 14G2a 检测双唾液酸神经节苷脂 GD2 &的水平,已发表验证可用于 FC、IF、IH。

Biochem/physiol Actions

与人 GD2 神经节苷脂特异性反应。

Other Notes

浓度:请参考批次特异性浓缩物的检验报告。

Physical form

形式:纯化
溶于0.02 M PB pH值7.6、0.25 M NaCl、含有0.1%叠氮化钠的细胞培养上清液。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Christian M Seitz et al.
Oncoimmunology, 9(1), 1683345-1683345 (2020-02-01)
Expression of the disialoganglioside GD2 has been identified as a marker antigen associated with a breast cancer stem-like cell (BCSC) phenotype. Here, we report on the evaluation of GD2 as a BCSC-specific target antigen for immunotherapy. GD2 expression was confirmed
Patrizia Garbati et al.
International journal of molecular sciences, 22(13) (2021-07-03)
High-risk neuroblastoma (HR-NB) still remains the most dangerous tumor in early childhood. For this reason, the identification of new therapeutic approaches is of fundamental importance. Recently, we combined the conventional pharmacological approach to NB, represented by cisplatin, with fendiline hydrochloride
Martin V Kolev et al.
Journal of immunology (Baltimore, Md. : 1950), 184(11), 6035-6042 (2010-04-28)
Tumor cells escape clearance by complement by abundantly expressing CD59 and other membrane complement regulators. Recently, we designed a peptide derived from the neural-restrictive silencer factor (REST), REST68, which we showed to inhibit expression of CD59 in tumors lacking the
Hideki Yoshida et al.
Scientific reports, 10(1), 1199-1199 (2020-01-29)
β-1,4-N-Acetyl-Galactosaminyltransferase 1 (B4GALNT1) encodes the key enzyme B4GALNT1 to generate gangliosides GM2/GD2. GM2/GD2 gangliosides are surface glycolipids mainly found on brain neurons as well as peripheral nerves and skin melanocytes and are reported to exacerbate the malignant potential of melanomas.
Patrizia Garbati et al.
Biomedicines, 8(11) (2020-11-07)
To overcome the lack of effective pharmacological treatments for high-risk neuroblastoma (HR-NB), the development of novel in vitro and in vivo models that better recapitulate the disease is required. Here, we used an in vitro multiclonal cell model encompassing NB

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持